Cargando…
Ulipristal acetate before high complexity endoscopic (hysteroscopic, laparoscopic) myomectomy – a mini-review
Uterine myomas (fibromas, leiomyomas) are the most common tumours in women, and their clinical signs and symptoms are presented by 25-40% of patients with these benign tumours. According to current guidelines, the armamentarium for myoma management consists of: medical therapy (GnRH, SPRMs), non-sur...
Autor principal: | Baranowski, Włodzimierz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5327621/ https://www.ncbi.nlm.nih.gov/pubmed/28250723 http://dx.doi.org/10.5114/pm.2016.65664 |
Ejemplares similares
-
The Use of Ulipristal Acetate (Esmya) Prior to Laparoscopic Myomectomy: Help or Hindrance?
por: Mallick, Rebecca, et al.
Publicado: (2019) -
Ulipristal Acetate in Myomectomy Optimization in an Infertile Patient with Giant Myomas
por: de la Fuente, Elena, et al.
Publicado: (2016) -
Hysteroscopic myomectomy
por: Piecak, Karolina, et al.
Publicado: (2017) -
Pre-treatment with GnRHa or ulipristal acetate prior to laparoscopic and laparotomic myomectomy: A systematic review and meta-analysis
por: de Milliano, Inge, et al.
Publicado: (2017) -
Hysteroscopic Myomectomy: Our Experience and Review
por: Muñoz, J. L., et al.
Publicado: (2003)